cronos group glp-1 receptor agonist weight management diabetes treatments Frontiers Indications for GLP-1/GIP RA Summary

We already know that GLP-1s act on the brain in various ways

other outcomes were cardiovascular and total death, nonfatal myocardial infarction (MI), nonfatal stroke, hospitalization for heart failure (HHF), and renal outcome

Weight loss patches are a new trend in the weight loss industry

In a trial, people lost 75% fat and 25% muscle.

Tirzepatide is a promising drug withdual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor activation that has revolutionized the treatment of type 2 diabetesmellitus (T2DM) as an adjunct to ...

Allulose, a rare sugar, has been shown to stimulate GLP-1, reduce blood sugar spikes, and help control appetite without the side effects of medications